… of pulmonary exacerbations with inhaled antibiotics in people with cystic fibrosis improves
their quality of life, reduces time off school or work, and improves their long‐term lung function. …

… with only oral or inhaled antibiotics. Although clinical and … of the outcomes from oral or
inhaled treated exacerbations. … report treatment with antibiotics including IV, inhaled, or oral. …

… the addition of inhaled antibiotics to intravenous antibiotic PEx treatment in … inhaled antibiotics
to standard intravenous antibiotics during PEx treatment is associated with improved lung …

… The role of inhaled antibiotics for acute pulmonary exacerbation is … of inhaled antibiotics
in CF pulmonary exacerbations involving … antibiotics with or without inhaled antibiotics for CF …

… inhaled antibiotics as they apply to disease states other than cystic fibrosis. In reviewing the
literature surrounding the use of inhaled antibiotics, … time to first pulmonary exacerbation by a …

… Inhaled antibiotic prophylaxis has been successfully used in other respiratory conditions
such as non-cystic fibrosis bronchiectasis which itself might be present in COPD patients who …

… increase inhaled antibiotic use to treat pulmonary exacerbations. The use of inhaled antibiotics
to treat pulmonary exacerbations … Inhaled antibiotics can augment oral therapy for milder …

… pulmonary exacerbations in CF. In this review, the efficacy and safety of the currently available
inhaled antibiotics for lung … Moreover, the effects of long-term inhaled antibiotic therapy for …

… infection and frequent exacerbations. Our data suggest that inhaled antibiotics consistently
achieve … The clinical significance of the pooled exacerbation benefit observed in our study is …

… within the previous 6 months, and 48% received oral and/or inhaled antibiotics prior to IV
antibiotic initiation. Forty percent had ≥ 10% FEV 1 decrease from their best value recorded in …